GMAB · Categories · Upgrades
GMAB - Analyst upgrades
Genmab A/S (GMAB) analyst upgrades - real-time wire coverage filtered to Upgrades only.
Recent Upgrades for GMAB
- Genmab upgraded by AnalystAnalyst upgraded Genmab from Neutral to Overweight
- Genmab upgraded by TD Cowen with a new price targetTD Cowen upgraded Genmab from Hold to Buy and set a new price target of $43.00
- Genmab upgraded by GoldmanGoldman upgraded Genmab from Neutral to Buy
- Genmab upgraded by Guggenheim with a new price targetGuggenheim upgraded Genmab from Neutral to Buy and set a new price target of $43.00
- Genmab upgraded by William BlairWilliam Blair upgraded Genmab from Mkt Perform to Outperform
- Genmab upgraded by Leerink Partners with a new price targetLeerink Partners upgraded Genmab from Market Perform to Outperform and set a new price target of $27.00
- Genmab upgraded by RBC Capital MktsRBC Capital Mkts upgraded Genmab from Sector Perform to Outperform
- Genmab upgraded by BMO Capital Markets with a new price targetBMO Capital Markets upgraded Genmab from Market Perform to Outperform and set a new price target of $48.00 from $46.00 previously
- Genmab upgraded by UBSUBS upgraded Genmab from Neutral to Buy
- Genmab upgraded by Deutsche BankDeutsche Bank upgraded Genmab from Hold to Buy
- Genmab upgraded by DNB MarketsDNB Markets upgraded Genmab from Sell to Buy
- Genmab upgraded by UBSUBS upgraded Genmab from Neutral to Buy
- Genmab upgraded by HC Wainwright & Co. with a new price targetHC Wainwright & Co. upgraded Genmab from Neutral to Buy and set a new price target of $47.00
- Genmab A/S upgraded by DNB MarketsDNB Markets upgraded Genmab A/S from Sell to Buy
- Genmab A/S upgraded by DanskeDanske upgraded Genmab A/S from Hold to Buy